\-\ Texto\\:\\ \ \(0\)\
\-\ pt\\ has\\ known\\ rheumatoid\\ arthritis\\.\ \(0\)\
\-\ pharmacologic\\ therapy\\ is\\ the\\ therapeutic\\ mainstay\\ for\\ all\\ patients\\ except\\ those\\ in\\ remission\\.\\ four\\ main\\ classes\\ of\\ drugs\\ are\\ currently\\ used\\:1\\)\\ analgesics\\ \\â\\€\\”\\ drugs\\ that\\ only\\ provide\\ analgesia\\ include\\ acetaminophen\\ \\(eg\\,\\ paracetamol\\)\\,\\ tramadol\\ \\(ultram\\)\\,\\ locally\\ applied\\ capsaicin\\ \\(zostrix\\)\\,\\ and\\ narcotics\\ \\(eg\\,\\ codeine\\)\\;\\ however\\,\\ narcotics\\ should\\ be\\ avoided\\ because\\ of\\ their\\ addictive\\ properties\\.\\ \\ 2\\)\\ nonsteroidal\\ anti\\-inflammatory\\ drugs\\ \\â\\€\\”\\ nsaids\\ have\\ both\\ analgesic\\ and\\ anti\\-inflammatory\\ properties\\ but\\ do\\ not\\ alter\\ disease\\ outcomes\\.\\ \\ agents\\ that\\ block\\ prostaglandin\\ production\\ by\\ selectively\\ inhibiting\\ the\\ cox\\-2\\ isoform\\ appear\\ to\\ share\\ analgesic\\ and\\ antiinflammatory\\ activity\\ with\\ conventional\\ nsaids\\,\\ but\\ exhibit\\ significantly\\ less\\ gastroduodenal\\ toxicity\\.\\ \\ \\ 3\\)\\ glucocorticoids\\ \\â\\€\\”\\ prednisone\\ or\\ prednisolone\\ are\\ most\\ commonly\\ used\\ to\\ suppress\\ inflammation\\,\\ and\\ may\\ be\\ administered\\ orally\\,\\ intravenously\\,\\ or\\ by\\ intraarticular\\ injection\\.\\ \\ 4\\)\\ saards\\ or\\ dmards\\ \\â\\€\\”\\ a\\ miscellaneous\\ group\\ of\\ drugs\\ termed\\ slow\\-acting\\ antirheumatic\\ drugs\\ \\(saards\\)\\ or\\ disease\\-modifying\\ antirheumatic\\ drugs\\ \\(dmards\\)\\ have\\ the\\ potential\\ to\\ reduce\\ or\\ prevent\\ joint\\ damage\\,\\ preserve\\ joint\\ integrity\\ and\\ function\\,\\ reduce\\ health\\ costs\\,\\ and\\ maintain\\ economic\\ productivity\\.\\*\\ such\\ agents\\ include\\ azathioprine\\,\\ cyclosporine\\,\\ d\\-penicillamine\\,\\ gold\\ salts\\,\\ hydroxychloroquine\\,\\ leflunomide\\,\\ methotrexate\\,\\ and\\ sulfasalazine\\.\ \(0\)\
\-\ \\*o\\'dell\\,\\ jr\\.\\ combination\\ dmard\\ therapy\\ for\\ rheumatoid\\ arthritis\\:\\ a\\ step\\ closer\\ to\\ the\\ goal\\.\\ ann\\ rheum\\ dis\\ 1996\\;\\ 55\\:781\\.\ \(0\)\
\-\ pa\\ \\ and\\ lateral\\ radiographs\\ of\\ the\\ hands\\ and\\ wrists\\ show\\ periarticular\\ osteopenia\\.\\ subluxations\\,\\ flexion\\ and\\ extension\\ deformities\\ including\\ boutonniere\\ and\\ swan\\-neck\\ deformities\\,\\ and\\ joint\\ space\\ narrowing\\ are\\ present\\ at\\ the\\ proximal\\ interphalangeal\\ joints\\ and\\ joint\\ space\\ narrowing\\ at\\ the\\ intercarpal\\ joints\\.\\ both\\ first\\ metacarpophalangeal\\ joints\\ are\\ ankylosed\\ with\\ surgical\\ pins\\ traversing\\ these\\ joints\\.\\ \\ joint\\ prostheses\\ are\\ present\\ at\\ the\\ left\\ 2nd\\ and\\ 3rd\\ metacarpo\\-phalangeal\\ joints\\ and\\ the\\ right\\ 2nd\\-5th\\ metacarpophalangeal\\ joints\\.\ \(0\)\
\-\ rheumatoid\\ arthritis\ \(67\)\
\-\ findings\\ consistent\\ with\\ advanced\\ inflammatory\\ arthropathy\\ with\\ post\\-surgical\\ changes\\ and\\ ankyloses\\ as\\ described\\ above\\ \\ and\\ consistent\\ with\\ the\\ patient\\'s\\ known\\ rheumatoid\\ arthritis\\.\ \(0\)\
\-\ 39\\ y\\/o\\ male\\ retired\\ army\\ personnel\\ with\\ known\\ rheumatoid\\ arthritis\\ referred\\ by\\ orthopaedics\\ for\\ routine\\ follow\\-up\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\”\\:\\ 0\\.07811469389195011\ \(0\)\
\-\ drugs\\:\\ 0\\.07676705466251055\ \(0\)\
\-\ joints\\:\\ 0\\.06358119748826128\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.05469369825006733\ \(0\)\
\-\ arthritis\\:\\ 0\\.049467919377276216\ \(0\)\
\-\ saards\\:\\ 0\\.04778058766377506\ \(0\)\
\-\ antirheumatic\\:\\ 0\\.04778058766377506\ \(0\)\
\-\ dmards\\:\\ 0\\.04402369237618728\ \(0\)\
\-\ analgesic\\:\\ 0\\.040266797088599496\ \(0\)\
\-\ joint\\:\\ 0\\.03744484085422874\ \(0\)\
\-\ narcotics\\:\\ 0\\.03650990180101172\ \(0\)\
\-\ properties\\:\\ 0\\.03650990180101172\ \(0\)\
\-\ metacarpophalangeal\\:\\ 0\\.035871511363849744\ \(0\)\
\-\ anti\\-inflammatory\\:\\ 0\\.02934591350842462\ \(0\)\
\-\ eg\\:\\ 0\\.027786661083211716\ \(0\)\
\-\ agents\\:\\ 0\\.02714827064604975\ \(0\)\
\-\ reduce\\:\\ 0\\.026160077926299315\ \(0\)\
\-\ deformities\\:\\ 0\\.026160077926299315\ \(0\)\
\-\ \\*\\:\\ 0\\.025772766468401515\ \(0\)\
\-\ nsaids\\:\\ 0\\.024990925770057088\ \(0\)\
\-\ used\\:1\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ paracetamol\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ ultram\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ capsaicin\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ zostrix\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ isoform\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ slow\\-acting\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ o\\'dell\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ dmard\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ 55\\:781\\.\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ swan\\-neck\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ ankylosed\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ metacarpo\\-phalangeal\\:\\ 0\\.02389029383188753\ \(0\)\
\-\ addictive\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ prostaglandin\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ cox\\-2\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ antiinflammatory\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ prednisolone\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ disease\\-modifying\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ costs\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ productivity\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ salts\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ leflunomide\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ boutonniere\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ 2nd\\-5th\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ personnel\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ known\\:\\ 0\\.02198415515824244\ \(0\)\
\-\ codeine\\:\\ 0\\.0209130247569062\ \(0\)\
\-\ inhibiting\\:\\ 0\\.0209130247569062\ \(0\)\
\-\ share\\:\\ 0\\.0209130247569062\ \(0\)\
\-\ economic\\:\\ 0\\.0209130247569062\ \(0\)\
\-\ d\\-penicillamine\\:\\ 0\\.0209130247569062\ \(0\)\
\-\ intercarpal\\:\\ 0\\.0209130247569062\ \(0\)\
\-\ selectively\\:\\ 0\\.020133398544299748\ \(0\)\
\-\ intravenously\\:\\ 0\\.020133398544299748\ \(0\)\
\-\ hydroxychloroquine\\:\\ 0\\.020133398544299748\ \(0\)\
\-\ ankyloses\\:\\ 0\\.020133398544299748\ \(0\)\
\-\ miscellaneous\\:\\ 0\\.019528673472987527\ \(0\)\
\-\ sulfasalazine\\:\\ 0\\.019528673472987527\ \(0\)\
\-\ rheum\\:\\ 0\\.019528673472987527\ \(0\)\
\-\ \\)\\:\\ 0\\.01933706482691884\ \(0\)\
\-\ classes\\:\\ 0\\.01903457711311231\ \(0\)\
\-\ tramadol\\:\\ 0\\.01903457711311231\ \(0\)\
\-\ orally\\:\\ 0\\.01903457711311231\ \(0\)\
\-\ pharmacologic\\:\\ 0\\.018616824593255244\ \(0\)\
\-\ acetaminophen\\:\\ 0\\.018616824593255244\ \(0\)\
\-\ nonsteroidal\\:\\ 0\\.018616824593255244\ \(0\)\
\-\ azathioprine\\:\\ 0\\.018616824593255244\ \(0\)\
\-\ cyclosporine\\:\\ 0\\.018616824593255244\ \(0\)\
\-\ subluxations\\:\\ 0\\.018616824593255244\ \(0\)\
\-\ prostheses\\:\\ 0\\.018616824593255244\ \(0\)\
\-\ narrowing\\:\\ 0\\.01857152679756096\ \(0\)\
\-\ mainstay\\:\\ 0\\.01825495090050586\ \(0\)\
\-\ pins\\:\\ 0\\.01825495090050586\ \(0\)\
\-\ analgesia\\:\\ 0\\.017935755681924872\ \(0\)\
\-\ gastroduodenal\\:\\ 0\\.017935755681924872\ \(0\)\
\-\ suppress\\:\\ 0\\.017935755681924872\ \(0\)\
\-\ preserve\\:\\ 0\\.017935755681924872\ \(0\)\
\-\ orthopaedics\\:\\ 0\\.017935755681924872\ \(0\)\
\-\ avoided\\:\\ 0\\.01765022582919364\ \(0\)\
\-\ alter\\:\\ 0\\.01765022582919364\ \(0\)\
\-\ retired\\:\\ 0\\.01765022582919364\ \(0\)\
\-\ step\\:\\ 0\\.017391932658992217\ \(0\)\
\-\ ann\\:\\ 0\\.017391932658992217\ \(0\)\
\-\ dis\\:\\ 0\\.017391932658992217\ \(0\)\
\-\ traversing\\:\\ 0\\.01715612946931842\ \(0\)\
\-\ army\\:\\ 0\\.01715612946931842\ \(0\)\
\-\ \\,\\:\\ 0\\.016873527118963713\ \(0\)\
\-\ glucocorticoids\\:\\ 0\\.016738376949461353\ \(0\)\
\-\ remission\\:\\ 0\\.016376503256711968\ \(0\)\
\-\ integrity\\:\\ 0\\.016376503256711968\ \(0\)\
\-\ closer\\:\\ 0\\.016376503256711968\ \(0\)\
\-\ toxicity\\:\\ 0\\.01621220888864575\ \(0\)\
\-\ intraarticular\\:\\ 0\\.01621220888864575\ \(0\)\
\-\ locally\\:\\ 0\\.01591078440325219\ \(0\)\
\-\ outcomes\\:\\ 0\\.01591078440325219\ \(0\)\
\-\ interphalangeal\\:\\ 0\\.01591078440325219\ \(0\)\
\-\ are\\:\\ 0\\.015784198814764252\ \(0\)\
\-\ jr\\:\\ 0\\.015771778185399748\ \(0\)\
\-\ applied\\:\\ 0\\.015639555518273916\ \(0\)\
\-\ periarticular\\:\\ 0\\.015639555518273916\ \(0\)\
\-\ termed\\:\\ 0\\.015513485015198326\ \(0\)\
\-\ analgesics\\:\\ 0\\.015393019533976555\ \(0\)\
\-\ exhibit\\:\\ 0\\.015393019533976555\ \(0\)\
\-\ space\\:\\ 0\\.015320092179277153\ \(0\)\
\-\ gold\\:\\ 0\\.015277681825524532\ \(0\)\
\-\ goal\\:\\ 0\\.015060763918550178\ \(0\)\
\-\ wrists\\:\\ 0\\.015060763918550178\ \(0\)\
\-\ post\\-surgical\\:\\ 0\\.015060763918550178\ \(0\)\
\-\ block\\:\\ 0\\.014958486606943548\ \(0\)\
\-\ methotrexate\\:\\ 0\\.014764830877994644\ \(0\)\
\-\ 1996\\:\\ 0\\.01449805561291808\ \(0\)\
\-\ maintain\\:\\ 0\\.014178860394337096\ \(0\)\
\-\ production\\:\\ 0\\.0140323367594583\ \(0\)\
\-\ prednisone\\:\\ 0\\.013697339588815543\ \(0\)\
\-\ or\\:\\ 0\\.013570768956147799\ \(0\)\
\-\ osteopenia\\:\\ 0\\.013456289491209864\ \(0\)\
\-\ administered\\:\\ 0\\.013343355354622957\ \(0\)\
\-\ conventional\\:\\ 0\\.013130695150174463\ \(0\)\
\-\ therapeutic\\:\\ 0\\.013030312300092214\ \(0\)\
\-\ arthropathy\\:\\ 0\\.013030312300092214\ \(0\)\
\-\ include\\:\\ 0\\.012992701832142475\ \(0\)\
\-\ provide\\:\\ 0\\.012981481661873573\ \(0\)\
\-\ health\\:\\ 0\\.012840056856533276\ \(0\)\
\-\ therapy\\:\\ 0\\.012382876944393566\ \(0\)\
\-\ damage\\:\\ 0\\.012376756590561352\ \(0\)\
\-\ group\\:\\ 0\\.012048971738480968\ \(0\)\
\-\ hands\\:\\ 0\\.01198121753196222\ \(0\)\
\-\ significantly\\:\\ 0\\.01185058852974575\ \(0\)\
\-\ advanced\\:\\ 0\\.01185058852974575\ \(0\)\
\-\ both\\:\\ 0\\.011827642225941038\ \(0\)\
\-\ \\(\\:\\ 0\\.011745719125916432\ \(0\)\
\-\ except\\:\\ 0\\.011725967626651379\ \(0\)\
\-\ combination\\:\\ 0\\.011665742323711785\ \(0\)\
\-\ by\\:\\ 0\\.011568056123942072\ \(0\)\
\-\ 2nd\\:\\ 0\\.01154916404435219\ \(0\)\
\-\ prevent\\:\\ 0\\.011492703104236085\ \(0\)\
\-\ 3rd\\:\\ 0\\.011464907710829067\ \(0\)\
\-\ consistent\\:\\ 0\\.011356630183366955\ \(0\)\
\-\ potential\\:\\ 0\\.011151864656298324\ \(0\)\
\-\ \\;\\:\\ 0\\.01097789262033926\ \(0\)\
\-\ injection\\:\\ 0\\.010805432755187526\ \(0\)\
\-\ main\\:\\ 0\\.0107838387994987\ \(0\)\
\-\ 39\\:\\ 0\\.010762415548801916\ \(0\)\
\-\ flexion\\:\\ 0\\.01065776829642311\ \(0\)\
\-\ those\\:\\ 0\\.010537302815201337\ \(0\)\
\-\ present\\:\\ 0\\.010460752053830248\ \(0\)\
\-\ their\\:\\ 0\\.01013643525401808\ \(0\)\
\-\ four\\:\\ 0\\.010053043225110888\ \(0\)\
\-\ do\\:\\ 0\\.010053043225110888\ \(0\)\
\-\ have\\:\\ 0\\.010029474679485593\ \(0\)\
\-\ but\\:\\ 0\\.009878066672268497\ \(0\)\
\-\ described\\:\\ 0\\.00986278778155195\ \(0\)\
\-\ inflammation\\:\\ 0\\.009847519982857489\ \(0\)\
\-\ function\\:\\ 0\\.009817240035437094\ \(0\)\
\-\ pa\\:\\ 0\\.009685017368311262\ \(0\)\
\-\ appear\\:\\ 0\\.009478044526076644\ \(0\)\
\-\ at\\:\\ 0\\.009412708559606773\ \(0\)\
\-\ routine\\:\\ 0\\.00928576339878048\ \(0\)\
\-\ currently\\:\\ 0\\.009176620040683082\ \(0\)\
\-\ used\\:\\ 0\\.008883967905008026\ \(0\)\
\-\ commonly\\:\\ 0\\.008738567597440763\ \(0\)\
\-\ referred\\:\\ 0\\.008738567597440763\ \(0\)\
\-\ activity\\:\\ 0\\.008688473248730457\ \(0\)\
\-\ pt\\:\\ 0\\.00861019987705353\ \(0\)\
\-\ above\\:\\ 0\\.008487638635847741\ \(0\)\
\-\ including\\:\\ 0\\.00836156813277215\ \(0\)\
\-\ and\\:\\ 0\\.008293097825061555\ \(0\)\
\-\ extension\\:\\ 0\\.008266469705099332\ \(0\)\
\-\ because\\:\\ 0\\.008101675654704737\ \(0\)\
\-\ inflammatory\\:\\ 0\\.00803066651542554\ \(0\)\
\-\ that\\:\\ 0\\.0079998955477443\ \(0\)\
\-\ less\\:\\ 0\\.007842655838272853\ \(0\)\
\-\ first\\:\\ 0\\.007770957817847838\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.007533975586562987\ \(0\)\
\-\ should\\:\\ 0\\.007382678975308401\ \(0\)\
\-\ radiographs\\:\\ 0\\.007334067320330983\ \(0\)\
\-\ such\\:\\ 0\\.007239384254311253\ \(0\)\
\-\ be\\:\\ 0\\.007142312863652732\ \(0\)\
\-\ show\\:\\ 0\\.007108823670709014\ \(0\)\
\-\ only\\:\\ 0\\.006963175226246438\ \(0\)\
\-\ proximal\\:\\ 0\\.006952691549341504\ \(0\)\
\-\ changes\\:\\ 0\\.006636986385460869\ \(0\)\
\-\ all\\:\\ 0\\.006549928155640355\ \(0\)\
\-\ 4\\:\\ 0\\.006452498388019093\ \(0\)\
\-\ however\\:\\ 0\\.006448151912187183\ \(0\)\
\-\ y\\/o\\:\\ 0\\.006413628807099297\ \(0\)\
\-\ these\\:\\ 0\\.006026679381999567\ \(0\)\
\-\ patients\\:\\ 0\\.005993427098552916\ \(0\)\
\-\ for\\:\\ 0\\.00592770852555053\ \(0\)\
\-\ 3\\:\\ 0\\.005422697904353766\ \(0\)\
\-\ most\\:\\ 0\\.005346436698450071\ \(0\)\
\-\ \\'s\\:\\ 0\\.005105817393948632\ \(0\)\
\-\ may\\:\\ 0\\.005079480674520661\ \(0\)\
\-\ lateral\\:\\ 0\\.00500452044884702\ \(0\)\
\-\ 2\\:\\ 0\\.004986733052874109\ \(0\)\
\-\ findings\\:\\ 0\\.00492909738696466\ \(0\)\
\-\ surgical\\:\\ 0\\.004867809675478194\ \(0\)\
\-\ to\\:\\ 0\\.004629464590167873\ \(0\)\
\-\ has\\:\\ 0\\.004348780407843571\ \(0\)\
\-\ male\\:\\ 0\\.004187548883163884\ \(0\)\
\-\ disease\\:\\ 0\\.003785196588660445\ \(0\)\
\-\ the\\:\\ 0\\.003746593081399073\ \(0\)\
\-\ as\\:\\ 0\\.003502920070173788\ \(0\)\
\-\ not\\:\\ 0\\.0033463920643412885\ \(0\)\
\-\ \\:\\:\\ 0\\.0030630753820885233\ \(0\)\
\-\ left\\:\\ 0\\.002591071190441503\ \(0\)\
\-\ right\\:\\ 0\\.0024434463661528907\ \(0\)\
\-\ patient\\:\\ 0\\.002321387346656878\ \(0\)\
\-\ a\\:\\ 0\\.002149592421781037\ \(0\)\
\-\ with\\:\\ 0\\.0019025069282908901\ \(0\)\
\-\ is\\:\\ 0\\.001523823247655083\ \(0\)\
\-\ \\.\\:\\ 0\\.0014430705730628566\ \(0\)\
\-\ of\\:\\ 0\\.0012629138297884925\ \(0\)\
\-\ in\\:\\ 0\\.0011419979136592275\ \(0\)\
